Source: Oncotarget. Unidade: FMRP
Subjects: MELANOMA, RNA, PROLIFERAÇÃO CELULAR, EXPRESSÃO GÊNICA, TERAPÊUTICA MÉDICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOEDERT, Lucas et al. RMEL3, a novel BRAFV600E-associated long noncoding RNA, is required for MAPK and PI3K signaling in melanoma. Oncotarget, v. 7, n. 24, p. 36711-36718, 2016Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.9164. Acesso em: 06 nov. 2024.APA
Goedert, L., Pereira, C. G., Roszik, J., Plaça, J. R., Cardoso, C., Chen, G., et al. (2016). RMEL3, a novel BRAFV600E-associated long noncoding RNA, is required for MAPK and PI3K signaling in melanoma. Oncotarget, 7( 24), 36711-36718. doi:10.18632/oncotarget.9164NLM
Goedert L, Pereira CG, Roszik J, Plaça JR, Cardoso C, Chen G, Deng W, Yennu-Nanda VG, Silva Júnior WA da, Davies MA, Espreáfico EM. RMEL3, a novel BRAFV600E-associated long noncoding RNA, is required for MAPK and PI3K signaling in melanoma [Internet]. Oncotarget. 2016 ; 7( 24): 36711-36718.[citado 2024 nov. 06 ] Available from: https://doi.org/10.18632/oncotarget.9164Vancouver
Goedert L, Pereira CG, Roszik J, Plaça JR, Cardoso C, Chen G, Deng W, Yennu-Nanda VG, Silva Júnior WA da, Davies MA, Espreáfico EM. RMEL3, a novel BRAFV600E-associated long noncoding RNA, is required for MAPK and PI3K signaling in melanoma [Internet]. Oncotarget. 2016 ; 7( 24): 36711-36718.[citado 2024 nov. 06 ] Available from: https://doi.org/10.18632/oncotarget.9164
